Skip to content

About us

Founded in late 2018 as a spin-off from Uppsala University, MODSIM Pharma stands at the forefront of Drug Discovery innovation. We have developed solutions aimed at characterizing protein-ligand interactions and expediting ligand design.

Stemming from state-of-the-art research in a leading academic lab at Uppsala University, our company specializes in Structure-Based Drug Design (SBDD), employing physics-based proprietary methods and molecular simulations. Our computational chemistry toolbox enables us to efficiently identify and design optimized candidate compounds.

At MODSIM Pharma, we want to help you to enhance the efficiency of your drug discovery programs. We offer solutions encompassing virtual compound library design, accurate modeling of pharmacological targets, and physics-based virtual screening techniques. Our dedicated team of application scientists and experts ensures that we meet the diverse demands of pharmaceutical projects.

To maintain our position at the forefront of the industry, we continuously develop and improve our software, integrating artificial intelligence (AI) and machine learning (ML) approaches and optimizing code to adapt to evolving hardware. Our proprietary computational tools and expertise empower clients to efficiently screen chemical compounds for tailored pharmacological properties.

We offer flexible software licensing, computing services, scientific development and expert consulting. We’re here to support our clients in the Hit Identification, Hit-to-Lead and Lead Optimization stages of their drug discovery processes.

Contact us to learn how we can accelerate your Drug Discovery journey.